Newsletter of Phenomenology

Keeping phenomenologists informed since May 2002

Repository | Book | Chapter

181184

(1987) Technology and responsibility, Dordrecht, Springer.

Commercializing reproductive technologies

ethical issues

Anne Donchin

pp. 151-172

These allegations from the congressional testimony of a prominent reproductive biologist epitomize the reproductive researcher's case for social support and public funding. The speaker, Gary Hodgen, has claimed publicly that he resigned his former position at the National Institutes of Health in protest over U.S. governmental policy withholding federal funding for reproductive technology research. He is now scientific director at a medical school facility deriving much of its research funding from the treatment of infertile patients. At the time of these congressional hearings in the U.S., the British government had already released the Warnock Commission Report on Human Fertilization and Embryology; the Australian Waller Commission on Reproductive Technology and announced submission of its findings; and already several Western European countries had established investigatory bodies. The time was right, some believed, to consider the need for regulation in the U.S.

Publication details

DOI: 10.1007/978-94-015-6940-8_8

Full citation:

Donchin, A. (1987)., Commercializing reproductive technologies: ethical issues, in P. T. Durbin (ed.), Technology and responsibility, Dordrecht, Springer, pp. 151-172.

This document is unfortunately not available for download at the moment.